UnknownNot Applicable

Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.

Italy25 participantsStarted 2017-05-17

Plain-language summary

Fractionated radiosurgery will be delivered to atypical meningioma lesions in salvage setting for patients who present post-surgical residual lesion or develop recurrence.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients had residual or recurrent atypical meningioma (grade II) after surgery (Simpson score) * Age: ≥ 18 years old * Karnofsky performance Status ( KPS) ≥ 70 * Written consent Exclusion Criteria: * Pregnancy * Neurofibromatosis type 2 (NF2) * Concomitant aggressive haematological or solid neoplasm

What they're measuring

Neurological side effects

Timeframe: through study completion, up to 2 year

Trial details

NCT IDNCT05081908

SponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-07

Contact for this trial

Renato Mantegazza, MD

+39022394 crc@istituto-besta.it

View on ClinicalTrials.gov More Meningioma Atypical trials